 This is a 12 week Open labelled parallel-Randomised controlled pilot study - 50 patients with type 2 Diabetes mellitus was selected after satisfying the inclusion and exclusion criterias .Metformin and pioglitazone were continued and they are randomised into 2 groups at base line and was allotted into any of the two regimens. 